Advancing Hong Kong Pharmacy Profession Development – Local Continuing Education Programme

Second training session is coming!!!!

The Pharmaceutical Society of Hong Kong (PSHK) is launching a 3-year Continuing Education (CE) programme from 2019 to August 2021. This progarmme is funded by the Professional Services Advancement Support Scheme, the Commerce and Economic Development Bureau, the Government of HKSAR. Pharmacists practicing in all sectors can expect to gain useful knowledge from it.

This programme consists of 12 training sessions of different Medication Therapy Management (MTM) topics, focusing on pharmacotherapy for elderly. There will be attendance certificate for each session and also, if you finish 4 training sessions plus 4 practical MTM service sessions in the community (PSHK will make the arrangement) for our elders, PSHK will issue a MTM Certificate for you. Then you can specify that you are "PSHK Certified Geriatric Pharmacist"

Thank you everyone for your great support to our first training session and we have received many positive feedbacks for having a practical and enjoyable training session. Dr. Ip is an excellent and knowledgeable speaker and we are pleased to invite him again to speak on his specialty. In addition, Dr. Ip is going to attend the Asian Federation of Osteoporosis Society meetings in the late August, he promised to share with us the update information on Osteoporosis at our upcoming session.

The second training session will be held on September 2019. Please see the following details:

Topic:         Endocrine disorders in the older adults

Date:          10 September 2019 (Tue)

Time :        19:00-22:00

Venue:      Bamboo Education – School for Talents, 4/F, Star House, 3 Salisbury Road, Tsim Sha Tsui

Speaker:    Dr. Tai-Pang IP, Consultant Endocrinologist, Department of Medicine, Tung Wah Hospital, Hong Kong

Fee:            Free-of-charge


Programme enrollment and second training session’s registration:


Survey about CE development for pharmacist in Hong Kong:


More details of the programme:

Please fill in the enrollment form online to join this programme and register for the training session. You are also welcome to complete the survey to express your opinions on CE development. There are limited seats, don’t hesitate, come and join us! Should you have any enquiries, please feel free to contact us at


You can see Dr. Ip's profile below.

Brief Profile


Dr. Tai-Pang Ip

Dr. Ip graduated from the University of Hong Kong in 1989. He received his specialist training in Queen Mary Hospital and the Garvan Institute of Medical Research, Sydney, Australia and became a Specialist in Endocrinology, Diabetes & Metabolism in 1997.


Current Important Professional Appointments

1. Consultant Endocrinologist, Department of Medicine, Tung Wah Hospital, Hong Kong

2. Honorary Clinical Associate Professor, Faculty of Medicine, University of Hong Kong

3. Honorary Clinical Assistant Professor, Faculty of Dentistry, University of Hong Kong

4. Part-Time Lecturer, School of Professional and Continuing Education (SPACE), University of Hong Kong

5. Council Member, the Osteoporosis Society of Hong Kong

6. Council Member, the Hong Kong Society of Endocrinology, Metabolism & Reproduction

7. Examiner, Final MBBS Examination in Medicine, University of Hong Kong

8. Journal Reviewer, the International Journal of Rheumatic Diseases, the Hong Kong Medical Journal and the Rheumatology Practice & Research.


Past Important Professional Appointments

1. Past President, Osteoporosis Society of Hong Kong (OSHK) (2010-2012)

2. Elected Advisory Council Member, Asia-Pacific Regional Advisory Council, International Osteoporosis Foundation (2010-2014)

3. National Committee Member, Asian Federation of Osteoporosis Societies (AFOS) (2010-2012)

4. Invited Guest Teaching Faculty, ISCD Bone Densitometry Course in Hong Kong (2004, 2007, 2008, 2010, 2013), the ISCD-IOF Osteoporosis Course in Hong Kong (2016, 2019) and the AFOS Osteoporosis Teaching Course in Macau in 2015


Dr. IP is a well-known physician in the clinical therapeutics of osteoporosis and diabetes. He is the leading author of the 2013 OSHK Guidelines for Clinical Management of Postmenopausal Osteoporosis in Hong Kong. Dr. Ip has been very active in promoting personalized approach in the pharmacological treatment of osteoporosis and diabetes to the profession. In the past 20 years, Dr. Ip has delivered more than 200 lectures on osteoporosis & diabetes in local, regional and international scientific meetings. He is also very active in clinical research. He has been the principal investigators at the local centre for a number of multicentre international studies on diabetes and osteoporosis treatment. He has authored more than 30 journal articles and conference abstracts.


Advancing Hong Kong Pharmacy Profession Development – Local Continuing Education Programme